We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Hand-Held OCT Device to Simplify Early Detection of Retinal Disease

By HospiMedica International staff writers
Posted on 31 Dec 2013
A novel hand-held optical device quickly scans a patient’s entire retina and so could aid in detecting early signs of a host of retinal diseases, including diabetic retinopathy, glaucoma, and macular degeneration.

A team at the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) describes their new ophthalmic-screening instrument in a report by Lu, C.D. More...
et al., published by The Optical Society (Washington DC, USA), December 20, 2013, in the journal Biomedical Optics Express. Although others have created hand-held devices using similar technology, the new design is the first to combine cutting-edge technologies such as ultrahigh-speed 3D imaging, a tiny micro-electromechanical systems (MEMS) mirror for scanning, and a technique to correct for unintentional movement by the patient. These innovations should allow clinicians to collect comprehensive data with just one measurement.

Many eye diseases should be detected and treated long before any visual symptoms arise, but few people visit eye specialists regularly. The MIT group, in collaboration with the University of Erlangen and Praevium/Thorlabs, has developed this portable instrument to improve public access to eye care. "Hand-held instruments can enable screening a wider population outside the traditional points of care," said Prof. James Fujimoto, MIT. They can be used at a primary-care physician's office or even in the developing world.

The instrument uses optical coherence tomography (OCT), which sends beams of infrared light into the eye and onto the retina. Echoes of this light return to the instrument, which uses interferometry to measure changes in the time delay and magnitude of the returning light echoes, revealing the cross-sectional tissue structure of the retina, similar to radar or ultrasound imaging. Tabletop OCT imagers have become a standard of care in ophthalmology, and current generation hand-held scanners are used for imaging infants and monitoring retinal surgery. The MIT group turned a typically large instrument into a portable size by using a MEMS mirror to scan the OCT imaging beam. The new device can acquire images comparable in quality to the conventional tabletop OCT instruments used by ophthalmologists.

To deal with the motion instability of a hand-held device, the instrument takes multiple 3D images at high speeds, scanning one particular volume of the eye many times but with different scanning directions. This makes it possible to correct for distortions due to motion of the operator’s hand or the subject’s eye.

The next step, said Prof. Fujimoto, is to evaluate the technology in clinical settings; however, the device is still expensive. "The hand-held platform allows the diagnosis or screening to be performed in a much wider range of settings,” said Prof. Fujimoto. He envisions that in the future hand-held OCT technology can be used in many other medical specialties beyond ophthalmology, such as in applications ranging from surgical guidance to military medicine.

Related Links:

Massachusetts Institute of Technology
The Optical Society



Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Digital Radiography System (Ceiling Free)
Digix CF Series
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.